Artivion Recalls CryoPatch SynerGraft Pulmonary Human Cardiac Patch
Artivion, Inc. is recalling a CryoPatch SynerGraft Pulmonary Human Cardiac Patch because the donor was older than the specified age limit, raising concerns about potential graft dysfunction.
The agency’s classification
FDA (Devices): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as Class II, and the source identifies a potential hazard of premature graft dysfunction due to the donor age being outside specifications. The source does not report any illnesses, injuries, or deaths.
Plain-English summary
Artivion, Inc. is recalling one unit of the CryoPatch SynerGraft (SG) Pulmonary Human Cardiac Patch, Model SGP010. The recall is due to the cryopreserved pulmonary human cardiac patch being taken from a 64-year-old human donor, which is outside the specified age range of newborn to 60 years for cardiac tissue donors.
The patch was shipped on May 22, 2024, and implanted on June 5, 2024. The distribution was nationwide in the state of Illinois. The specific unit is identified by Serial/Donor Number 12617554/177871 and UDI-DI 00877234000478.
Due to limitations in long-term in vivo data, the possibility of premature graft dysfunction cannot be excluded. The source text does not report any illnesses, injuries, or deaths associated with this recall.
The recalled product
- Product
- CryoPatch SynerGraft (SG) Pulmonary Human Cardiac Patch, Model: SGP010
- Manufacturer
- Artivion, Inc
- Category
- Medical Device — Cardiac Patch
- Hazard
- Affected units
- 1
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Serial/Donor Number: 12617554/177871
- UDI-DI: 00877234000478
- Shipped: 22May2024
- Implanted: 05June2024
Distribution
Related recalls
Same manufacturer · Artivion, Inc
See all →- HighPulmonary Heart Valve Grafts Recalled Due to Invalid Test Results
FDA (Devices) · 2024-08-14
- HighFDA Recalls CryoPatch Cardiac Tissue Grafts Due to Invalid Test Results
FDA (Devices) · 2024-08-14
- HighCryoValve SG Heart Valve Recalled for Staphylococcus aureus Contamination
FDA (Devices) · 2024-04-24
Similar recalls
- HighFDA Recalls CryoPatch Cardiac Tissue Grafts Due to Invalid Test Results
FDA (Devices) · 2024-08-14
- HighPulmonary Heart Valve Grafts Recalled Due to Invalid Test Results
FDA (Devices) · 2024-08-14
- SevereCryoLife Recalls CryoPatch SG Pulmonary Human Cardiac Patch Units
FDA (Devices) · 2020-12-30
- HighCryoValve SG Heart Valve Recalled for Staphylococcus aureus Contamination
FDA (Devices) · 2024-04-24
- SevereCryoLife Pulmonary Hemi-Artery Patch Recalled for Donor Infection
FDA (Devices) · 2019-05-01
- HighCryoLife Pulmonary Cardiac Branch Recalled Due to Morphine Presence
FDA (Devices) · 2018-06-27